TrialSignal
Clinical trial intelligence report
Observational, Prospective Cohort Study of the Immunogenicity and Safety of SARS-CoV-2 Vaccines Administered During Pregnancy or Postpartum and Evaluation of Antibody Transfer and Durability in Infants
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT05031468-Jul 28, 2026
NCT ID
NCT05031468
Status
COMPLETED
Phase
registry-stage
Sponsor
Emory University
Executive brief
Investment-Ready Snapshot
Observational, Prospective Cohort Study of the Immunogenicity and Safety of SARS-CoV-2 Vaccines Administered During Pregnancy or Postpartum and Evaluation of Antibody Transfer and Durability in Infants is a registry-stage clinical asset sponsored by Emory University in COVID-19. SEO and diligence focus: Licensed or EUA SARS-CoV-2 vaccine, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT05031468
Indication
COVID-19
Modality
protein therapy
Target
Licensed or EUA SARS-CoV-2 vaccine
Intervention
Licensed or EUA SARS-CoV-2 vaccine
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.